1 Min Read
May 10 (Reuters) - Kempharm Inc
* Kempharm, Inc. reports first quarter 2017 results
* Q1 loss per share $0.84
* Q1 earnings per share view $-0.63 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.